| Products/Services Used | Details | Operation |
|---|---|---|
| Synthetic Guide RNA> | Therapeutic sgRNAs (HBG1/2, BCL11A_1620 and BCL11A_1617) were chemically end-modified and synthesized from GenScript. | Get A Quote |
With the increasing use of CRISPR-Cas9, detecting off-target events is essential for safety. Current methods primarily focus on guide RNA (gRNA) sequence mismatches, often overlooking the impact of DNA topology in regulating off-target activity. Here we present TOPO-seq, a high-throughput and sensitive method that identifies genome-wide off-target effects of Cas9 and base editors while accounting for DNA topology. TOPO-seq revealed that topology-induced off-target sites frequently harbor higher mismatches than the relaxed DNA sequence, with over 50% of off-target sites containing six mismatches, which are usually overlooked using previous methods. Applying TOPO-seq to three therapeutic gRNAs in hematopoietic st... More